Jefferies Maintains Buy on LifeStance Health Gr, Raises Price Target to $9
Jefferies Maintains Buy on LifeStance Health Gr, Raises Price Target to $9
傑富瑞維持對LifeStance Health Gr的買入,將目標股價上調至9美元
Jefferies analyst Brian Tanquilut maintains LifeStance Health Gr (NASDAQ:LFST) with a Buy and raises the price target from $8 to $9.
傑富瑞分析師布萊恩·坦基盧特維持LifeStance Health Gr(納斯達克股票代碼:LFST)的買入並將目標股價從8美元上調至9美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。